Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sertoli-Leydig cell tumor.

T Lantzsch1, S Stoerer, K Lawrenz

  • 1Department of Gynecology, Martin-Luther-University, Halle-Wittenberg, Halle/Saale, Germany. tilmann.lantzsch@medizin.uni-halle.de

Archives of Gynecology and Obstetrics
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Does preoperative locally applied estrogen treatment facilitate prolapse-associated symptoms in postmenopausal women with symptomatic pelvic organ prolapse? A randomised controlled double-masked, placebo-controlled, multicentre study.

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

[Chorioretinal atrophy in pediatric cerebral folate deficiency-a preventable disease?]

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2020
Same author

[Not Available].

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2016
Same author

Gestational and Non-gestational Trophoblastic Disease. Guideline of the DGGG, OEGGG and SGGG (S2k Level, AWMF Registry No. 032/049, December 2015).

Geburtshilfe und Frauenheilkunde·2016
Same author

[Treatment of myofascial lumbar dorsal pain. Effective clinical diagnostics and therapy].

Schmerz (Berlin, Germany)·2014
Same author

Survival after neoadjuvant chemotherapy with or without bevacizumab or everolimus for HER2-negative primary breast cancer (GBG 44-GeparQuinto)†.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same journal

Phototoxicity of brightfield live-cell imaging on murine ovarian follicles.

Archives of gynecology and obstetrics·2026
Same journal

First-trimester lipoprotein(a) and longitudinal renal biomarker trajectories preceding preeclampsia: a pilot cohort study.

Archives of gynecology and obstetrics·2026
Same journal

Correction: Intraoperative hemodynamics and anesthetic implications in superobese parturients undergoing cesarean delivery: a retrospective cohort analysis.

Archives of gynecology and obstetrics·2026
Same journal

Ophthalmic artery Doppler: reference values in low-risk pregnant women.

Archives of gynecology and obstetrics·2026
Same journal

Diagnostic and treatment delay in women with cancer in pregnancy: a case-based study.

Archives of gynecology and obstetrics·2026
Same journal

One-year outcome after laser treatment of vulvar lichen sclerosus: a prospective observational trial.

Archives of gynecology and obstetrics·2026
See all related articles

This case study details an 11-year-old girl with an ovarian Sertoli-Leydig cell tumor, a rare sex-cord stromal tumor. Surgical removal led to normalized hormone levels and no recurrence at six months.

Area of Science:

  • Gynecologic Oncology
  • Endocrinology
  • Pediatric Pathology

Background:

  • Sertoli-Leydig cell tumors are rare ovarian neoplasms, comprising <0.5% of all ovarian tumors.
  • These sex-cord stromal tumors are typically unilateral and predominantly benign.
  • They can present with significant hormonal abnormalities due to androgen production.

Observation:

  • A case of an 11-year-old girl presenting with an ovarian SLCT is described.
  • Pre-operative hormonal analysis revealed elevated estradiol and progesterone, with significantly increased testosterone and androstenedione levels.

Findings:

  • The patient underwent a left salpingo-oophorectomy for the intermediate-grade tumor.
  • Post-operatively, the patient showed no evidence of recurrence at 6 months, and sex hormone levels normalized.

Related Experiment Videos

Implications:

  • Treatment for SLCTs requires individualization based on patient age, tumor stage, and differentiation grade.
  • This case underscores the importance of hormonal evaluation and surgical management in pediatric patients with SLCTs.